Transformational therapies for the treatment of cardiovascular diseases

Learn More

Addressing Unmet Cardiovascular Needs

Orchestra BioMed is a therapeutic device company focused on the development and commercialization of high impact, data-driven, transformational solutions for targeted high value unmet medical needs. Our main focus is on developing new therapies for cardiovascular diseases which are the leading cause of death worldwide, taking the lives of 17.7 million people each year or 31% of all global deaths according to the World Health Organization. Cardiovascular diseases are the leading cause of death in the U.S. as well, causing 774,165 deaths or over 28.5% of all deaths in 2015 according to the CDC. Despite medical advancements, there remains significant need for improvement in clinical outcomes associated with cardiovascular disease.

[   17.7M people die every year from cardiovascular diseases   ]

Product Pipeline Overview

Product pipeline targets large initial markets with significant growth opportunities in expansion future indications.

Learn More

Transformational Therapies for Artery Disease & Hypertension

Innovative therapies target clear unmet needs in high risk patients

News & Events

Three-Month Data from the Moderato-HTN Trial Published

December 23, 2017

American Heart Association Journal

3-months data from Moderato-HTN first-in-human clinical study was published in the American Heart Association Journal. The study was an open-label, single-arm, multicenter, prospective trial investigating the safety and efficacy of BackBeat PHC pacing therapy in patients with persistent hypertension indicated for implantation or replacement of a dual-chamber pacemaker.

Abstract on BackBeat® CNT Awarded Best Abstract at the International Conference for Innovations

December 5, 2017

International Conference for Innovation (ICI), Tel Aviv, Israel

BackBeat’s abstract entitled “Two-Year Experience with Programmable Hypertension Control Therapy: A Novel Treatment for Hypertension” was awarded best abstract at the International Conference for Innovation (ICI) that took place in Tel Aviv, Israel on December 3-5, 2017 and helped create a lot of buzz throughout the conference about this transformational therapy.

Read All News